Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an adjunct to PENG block for pain control in hip surgery
RBR-28swytbNot yet recruiting
- Sponsor
- IAMSPE
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in hip fracture and hip osteoarthritis (2 arms), sponsored by IAMSPE. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hip fracturehip osteoarthritis
Beyond the preview
Go deeper on RBR-28swytb.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-28swytb.